TRINTELLIX® is the first antidepressant to include head-to-head data in its labeling that
showed improvement in treatment-emergent sexual dysfunction in patients with MDD who switched from certain SSRI treatments.
You are about to leave the NewsRoom website and enter a website operated by an independent third party. The links to third-party websites are provided solely for your convenience. Lundbeck does not control the opinions, claims, or comments contained on any third-party website linked to NewsRoom.com, and your activities at those websites will be governed by the policies and practices of those third parties.
Select "OK" to proceed to this third-party website or "Cancel" to stay at NewsRoom.com.